{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:11:45Z","timestamp":1768353105611,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T00:00:00Z","timestamp":1722816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1245\/s10434-024-15997-0","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T16:30:13Z","timestamp":1722875413000},"page":"7679-7681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Patient Experience Through Qualitative Methods: The Missing Piece of Cytoreductive Surgery and HIPEC Research"],"prefix":"10.1245","volume":"31","author":[{"given":"Erin P.","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-2919","authenticated-orcid":false,"given":"Alissa","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,5]]},"reference":[{"issue":"3","key":"15997_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJV Driel","year":"2018","unstructured":"Driel WJV, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1708618.","journal-title":"N Engl J Med."},{"issue":"18_suppl","key":"15997_CR2","doi-asserted-by":"publisher","first-page":"LBA3503","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA3503","volume":"36","author":"F Quenet","year":"2018","unstructured":"Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018;36(18_suppl):LBA3503. https:\/\/doi.org\/10.1200\/JCO.2018.36.18_suppl.LBA3503.","journal-title":"J Clin Oncol."},{"issue":"1","key":"15997_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","volume":"245","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245(1):104\u20139. https:\/\/doi.org\/10.1097\/01.sla.0000231705.40081.1a.","journal-title":"Ann Surg."},{"issue":"8","key":"15997_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","volume":"6","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6(8):727\u201331. https:\/\/doi.org\/10.1007\/s10434-999-0727-7.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"15997_CR5","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/cncr.32881","volume":"126","author":"Group CCW","year":"2020","unstructured":"Group CCW. The Chicago Consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Cancer. 2020;126(11):2525\u201333. https:\/\/doi.org\/10.1002\/cncr.32881.","journal-title":"Cancer."},{"issue":"36","key":"15997_CR6","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/jco.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27(36):6237\u201342. https:\/\/doi.org\/10.1200\/jco.2009.23.9640.","journal-title":"J Clin Oncol."},{"issue":"1","key":"15997_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejso.2020.05.021","volume":"47","author":"M Alyami","year":"2021","unstructured":"Alyami M, Bonnot PE, Mercier F, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur J Surg Oncol. 2021;47(1):123\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2020.05.021.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"15997_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1245\/s10434-021-10505-0","volume":"29","author":"M Raoof","year":"2022","unstructured":"Raoof M, Malhotra G, Kohut A, et al. PIPAC for the Treatment of gynecologic and gastrointestinal peritoneal metastases: technical and logistic considerations of a phase 1 trial. Ann Surg Oncol. 2022;29(1):175\u201385. https:\/\/doi.org\/10.1245\/s10434-021-10505-0.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"15997_CR9","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.1245\/s10434-020-08790-2","volume":"27","author":"SD Forsythe","year":"2020","unstructured":"Forsythe SD, Sasikumar S, Moaven O, et al. Personalized identification of optimal HIPEC perfusion protocol in patient-derived tumor organoid platform. Ann Surg Oncol. 2020;27(13):4950\u201360. https:\/\/doi.org\/10.1245\/s10434-020-08790-2.","journal-title":"Ann Surg Oncol."},{"key":"15997_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003109","author":"K Flatmark","year":"2021","unstructured":"Flatmark K, Torgunrud A, Fleten KG, et al. Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei. J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2021-003109.","journal-title":"J Immunother Cancer."},{"issue":"2","key":"15997_CR11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1245\/s10434-021-10769-6","volume":"29","author":"CR Pameijer","year":"2022","unstructured":"Pameijer CR. HIPEC trials and the US: a review and call to action. Ann Surg Oncol. 2022;29(2):866\u201372. https:\/\/doi.org\/10.1245\/s10434-021-10769-6.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"15997_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","volume":"149","author":"MD Jafari","year":"2014","unstructured":"Jafari MD, Halabi WJ, Stamos MJ, et al. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American college of surgeons national surgical quality improvement program. JAMA Surgery. 2014;149(2):170\u20135. https:\/\/doi.org\/10.1001\/jamasurg.2013.3640.","journal-title":"JAMA Surgery."},{"issue":"5","key":"15997_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jamcollsurg.2006.12.048","volume":"204","author":"EA Levine","year":"2007","unstructured":"Levine EA, Stewart JHT, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg. 2007;204(5):943\u201353. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2006.12.048.","journal-title":"J Am Coll Surg."},{"issue":"4","key":"15997_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1245\/s10434-017-6326-0","volume":"25","author":"AT Stearns","year":"2018","unstructured":"Stearns AT, Malcomson L, Punnett G, et al. Long-term quality of life after cytoreductive surgery and heated intraperitoneal chemotherapy for pseudomyxoma peritonei: a prospective longitudinal study. Ann Surg Oncol. 2018;25(4):965\u201373. https:\/\/doi.org\/10.1245\/s10434-017-6326-0.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"15997_CR15","first-page":"488","volume":"23","author":"N Kopanakis","year":"2018","unstructured":"Kopanakis N, Argyriou EO, Vassiliadou D, et al. Quality of life after cytoreductive surgery and HIPEC: a single centre prospective study. J BUON. 2018;23(2):488\u201393.","journal-title":"J BUON."},{"issue":"10","key":"15997_CR16","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1245\/s10434-020-08443-4","volume":"27","author":"D Steffens","year":"2020","unstructured":"Steffens D, Koh C, Ansari N, et al. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: early results from a prospective cohort study of 115 patients. Ann Surg Oncol. 2020;27(10):3986\u201394. https:\/\/doi.org\/10.1245\/s10434-020-08443-4.","journal-title":"Ann Surg Oncol."},{"key":"15997_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030788","author":"C Bakkers","year":"2023","unstructured":"Bakkers C, van de Vlasakker VCJ, Rovers KPB, et al. The impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) versus conventional surgery on patient-reported outcomes: a comparative cohort study between the CAIRO6 trial and the PROCORE study. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15030788.","journal-title":"Cancers (Basel)."},{"issue":"4","key":"15997_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/jso.23089","volume":"106","author":"KE Duckworth","year":"2012","unstructured":"Duckworth KE, McQuellon RP, Russell GB, et al. Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC). J Surg Oncol. 2012;106(4):376\u201380. https:\/\/doi.org\/10.1002\/jso.23089.","journal-title":"J Surg Oncol."},{"issue":"3","key":"15997_CR19","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-023-14618-6","volume":"31","author":"R Balachandran","year":"2024","unstructured":"Balachandran R, Thaysen HV, Christensen P, Zachariae R, Iversen LH. Biopsychosocial late effects after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases from colorectal and appendiceal cancer: a national prospective cohort study. Ann Surg Oncol. 2024;31(3):1959\u201369. https:\/\/doi.org\/10.1245\/s10434-023-14618-6.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"15997_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1245\/s10434-019-08064-6","volume":"27","author":"O Moaven","year":"2020","unstructured":"Moaven O, Votanopoulos KI, Shen P, et al. Health-related quality of life after cytoreductive surgery\/HIPEC for mucinous appendiceal cancer: results of a multicenter randomized trial comparing oxaliplatin and mitomycin. Ann Surg Oncol. 2020;27(3):772\u201380. https:\/\/doi.org\/10.1245\/s10434-019-08064-6.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"15997_CR21","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1245\/s10434-018-07120-x","volume":"26","author":"VA Francescutti","year":"2019","unstructured":"Francescutti VA, Maciver AH, Stewart E, et al. Characterizing the patient experience of CS\/HIPEC through in-depth interviews with patients: identification of key concepts in the development of a patient-centered program. Ann Surg Oncol. 2019;26(4):1063\u201370. https:\/\/doi.org\/10.1245\/s10434-018-07120-x.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"15997_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/scs.12412","volume":"31","author":"C Leo Swenne","year":"2017","unstructured":"Leo Swenne C, Jangland E, Arakelian E. Patients\u2019 experiences of their everyday life 14 months after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - a qualitative follow-up study. Scand J Caring Sci. 2017;31(4):904\u201313. https:\/\/doi.org\/10.1111\/scs.12412.","journal-title":"Scand J Caring Sci."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15997-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15997-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15997-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T14:07:55Z","timestamp":1728569275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15997-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,5]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["15997"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15997-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,5]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}